Market Closed -
Australian S.E.
02:10:46 2024-04-30 am EDT
|
5-day change
|
1st Jan Change
|
0.087
AUD
|
+6.10%
|
|
+2.35%
|
-20.91%
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
57.76
|
137.2
|
1,762
|
1,056
|
584.5
|
600.2
|
-
|
-
|
Enterprise Value (EV)
1 |
38.71
|
137.2
|
1,762
|
1,056
|
584.5
|
600.2
|
600.2
|
600.2
|
P/E ratio
|
-7.27
x
|
-11.9
x
|
-88.8
x
|
-26.9
x
|
-14.7
x
|
-4.39
x
|
-6.31
x
|
-10.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
14
x
|
32.6
x
|
-
|
-
|
-
|
-
|
-
|
13.7
x
|
EV / Revenue
|
14
x
|
32.6
x
|
-
|
-
|
-
|
-
|
-
|
13.7
x
|
EV / EBITDA
|
-7.11
x
|
-
|
-107
x
|
-
|
-11.9
x
|
-6.4
x
|
-10.3
x
|
-17
x
|
EV / FCF
|
-
|
-13.1
x
|
-131
x
|
-33.9
x
|
-18.6
x
|
-7.04
x
|
-11.2
x
|
-17.4
x
|
FCF Yield
|
-
|
-7.61%
|
-0.76%
|
-2.95%
|
-5.38%
|
-14.2%
|
-8.93%
|
-5.73%
|
Price to Book
|
-
|
2.29
x
|
27.1
x
|
7.63
x
|
3.11
x
|
4.1
x
|
5.86
x
|
10.3
x
|
Nbr of stocks (in thousands)
|
3,609,848
|
4,425,971
|
4,962,842
|
5,865,700
|
6,423,039
|
7,319,811
|
-
|
-
|
Reference price
2 |
0.0160
|
0.0310
|
0.3550
|
0.1800
|
0.0910
|
0.0820
|
0.0820
|
0.0820
|
Announcement Date
|
8/30/19
|
8/31/20
|
8/30/21
|
8/30/22
|
8/25/23
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4.127
|
4.21
|
-
|
-
|
-
|
-
|
-
|
43.78
|
EBITDA
1 |
-8.121
|
-
|
-16.5
|
-
|
-49.09
|
-93.8
|
-58
|
-35.3
|
EBIT
1 |
-8.184
|
-10.81
|
-18.47
|
-37.94
|
-41.02
|
-131.9
|
-116.1
|
-81.54
|
Operating Margin
|
-198.29%
|
-256.67%
|
-
|
-
|
-
|
-
|
-
|
-186.22%
|
Earnings before Tax (EBT)
1 |
-7.775
|
-10.51
|
-18.46
|
-37.87
|
-39.17
|
-118.1
|
-100.3
|
-68.87
|
Net income
1 |
-7.775
|
-10.51
|
-18.46
|
-37.87
|
-39.17
|
-116
|
-100.3
|
-68.87
|
Net margin
|
-188.39%
|
-249.61%
|
-
|
-
|
-
|
-
|
-
|
-157.3%
|
EPS
2 |
-0.002200
|
-0.002600
|
-0.004000
|
-0.006700
|
-0.006200
|
-0.0187
|
-0.0130
|
-0.008000
|
Free Cash Flow
1 |
-
|
-10.44
|
-13.42
|
-31.11
|
-31.47
|
-85.2
|
-53.6
|
-34.4
|
FCF margin
|
-
|
-248.06%
|
-
|
-
|
-
|
-
|
-
|
-78.57%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/30/19
|
8/31/20
|
8/30/21
|
8/30/22
|
8/25/23
|
-
|
-
|
-
|
Fiscal Period: June |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
-
|
1.835
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-41.8
|
-
|
-
|
EBIT
1 |
-
|
-5.907
|
-6.04
|
-12.43
|
-15.21
|
-22.73
|
-17.87
|
-23.15
|
-71.01
|
-52.02
|
-61.2
|
-63.34
|
Operating Margin
|
-
|
-321.91%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-6.063
|
-12.39
|
-14.83
|
-23.04
|
-17.39
|
-21.78
|
-68.71
|
-52.25
|
-51.8
|
-52.94
|
Net income
1 |
-4.791
|
-
|
-6.063
|
-12.39
|
-14.83
|
-23.04
|
-17.39
|
-21.78
|
-68.71
|
-52.25
|
-51.8
|
-52.94
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.001300
|
-
|
-0.001300
|
-0.002700
|
-0.002700
|
-0.004000
|
-0.002800
|
-0.003400
|
-0.0100
|
-0.0100
|
-0.0100
|
-0.0100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/26/20
|
8/31/20
|
2/26/21
|
8/30/21
|
2/27/22
|
8/30/22
|
2/28/23
|
8/25/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
19
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-10.4
|
-13.4
|
-31.1
|
-31.5
|
-85.2
|
-53.6
|
-34.4
|
ROE (net income / shareholders' equity)
|
-
|
-24.1%
|
-29.6%
|
-37.2%
|
-24%
|
-66%
|
-61%
|
-66%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
0.0100
|
0.0100
|
0.0200
|
0.0300
|
0.0200
|
0.0100
|
0.0100
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
0.13
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
3.11%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/30/19
|
8/31/20
|
8/30/21
|
8/30/22
|
8/25/23
|
-
|
-
|
-
|
Last Close Price
0.082
AUD Average target price
0.3533
AUD Spread / Average Target +330.89% Consensus |
1st Jan change
|
Capi.
|
---|
| -20.91% | 394M | | +1.77% | 42.86B | | +12.24% | 42.74B | | +43.17% | 41.36B | | -8.83% | 27.68B | | +7.44% | 25.15B | | -23.01% | 18.63B | | +30.56% | 12.37B | | -1.82% | 11.92B | | +8.35% | 11.21B |
Other Biotechnology & Medical Research
|